Key Takeaways Patients with appendiceal adenocarcinoma have a 7.5% risk of second primary cancer within 10 years. There is a 12% excess incidence of secondary primary cancers, particularly colorectal, ...

Colorectal adenocarcinoma is the third most frequent cancer globally and the second leading cause of cancer-related death. According to the WHO, there were nearly 2,000,000 new cases of CRC in ...

RAF1 and lung adenocarcinoma Beyond the development of drugs against KRAS, one of the most active research areas at the moment seeks to identify inhibitors of proteins, such as RAF1, responsible ...

Urachal adenocarcinoma closely resembles colorectal cancer at the level of RNA expression, which extends previous observations that urachal tumors harbor genomic alterations that are found in ...

Background: Recent reports indicate that the incidence of colorectal cancer in hitherto low incidence areas is increasing, and with a proportionate shift towards the right colon. Cancer in Nigeria ...

A window of opportunity is now open to design RAF1 degraders with an important therapeutic effect in patients with lung adenocarcinoma induced by KRAS oncogenes." Sara García-Alonso, CNIO ...